Work

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

Year: 2020

Type: review

Source: Clinical Microbiology and Infection

DOI: 10.1016/j.cmi.2020.03.008

Authors: A.-G. Märtson, M.G.G. Sturkenboom, J. Stojanova, D. Cattaneo, W. Hope, D. Marriott, A.E. Patanwala, C.A. Peloquin, S.G. Wicha, T.S. van der Werf, T. Tängdén, J.A. Roberts, M.N. Neely, J.-W.C. Alffenaar

Institutions: University Medical Center Groningen, University of Groningen, University of Valparaíso, ASST Fatebenefratelli Sacco, University of Liverpool, Royal Liverpool and Broadgreen University Hospital NHS Trust, Broadgreen Hospital, St Vincent's Hospital Sydney, The University of Sydney, Royal Prince Alfred Hospital, University of Florida, Universität Hamburg, Uppsala University, The University of Queensland, Université de Montpellier, Royal Brisbane and Women's Hospital, Centre Hospitalier Universitaire de Nîmes, Children's Hospital Los Angeles, Westmead Hospital

Language: English

Topic: Antibiotics Pharmacokinetics and Efficacy

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Health and Medical Research Council, H2020 Marie Skłodowska-Curie Actions

Awards: Redefining antibiotic dosing to reduce bacterial resistance, Local cardiac sex steroids - new therapeutic targets, G8258281038

OpenAlex ID: W3012503307

FWCI: 1.112

Cites: 85

Cited by: 55

Related to: 10